Ameriprise’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
12,963
-14,675
| -53% | -$417K | ﹤0.01% | 3602 |
|
|
2025
Q1 | $816K | Buy |
27,638
+194
| +0.7% | +$5.73K | ﹤0.01% | 3261 |
|
|
2024
Q4 | $798K | Buy |
27,444
+14,129
| +106% | +$411K | ﹤0.01% | 3308 |
|
|
2024
Q3 | $612K | Sell |
13,315
-26,729
| -67% | -$1.23M | ﹤0.01% | 3404 |
|
|
2024
Q2 | $1.64M | Buy |
40,044
+23,199
| +138% | +$948K | ﹤0.01% | 2950 |
|
|
2024
Q1 | $430K | Buy |
16,845
+5,495
| +48% | +$140K | ﹤0.01% | 3467 |
|
|
2023
Q4 | $103K | Buy |
+11,350
| New | +$103K | ﹤0.01% | 3811 |
|
|
2021
Q4 | – | Sell |
-8,360
| Closed | -$206K | – | 4034 |
|
|
2021
Q3 | $206K | Buy |
+8,360
| New | +$206K | ﹤0.01% | 3695 |
|